Literature DB >> 26027575

Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.

Jin Woo Park, Sun Jin Kim, Dong Sup Kwag, Sol Kim, Jeyoung Park, Yu Seok Youn, You Han Bae1, Eun Seong Lee.   

Abstract

In recent years, advances in biotechnology and protein engineering have enabled the production of large quantities of proteins and peptides as important therapeutic agents. Various researchers have used biocompatible functional polymers to prepare oral dosage forms of proteins and peptides for chronic use and for easier administration to enhance patient compliance. However, there is a need to enhance their safety and effectiveness further. Most macromolecules undergo severe denaturation at low pH and enzymatic degradation in the gastrointestinal tract. The macromolecules' large molecular size and low lipophilicity cause low permeation through the intestinal membrane. The major strategies that have been used to overcome these challenges (in oral drug carrier systems) can be classified as follows: enteric coating or encapsulation with pH-sensitive polymers or mucoadhesive polymers, co-administration of protease inhibitors, incorporation of absorption enhancers, modification of the physicochemical properties of the macromolecules, and site-specific delivery to the colon. This review attempts to summarize the various advanced oral delivery carriers, including nanoparticles, lipid carriers, such as liposomes, nano-aggregates using amphiphilic polymers, complex coacervation of oppositely charged polyelectrolytes, and inorganic porous particles. The particles were formulated and/or surface modified with functional polysaccharides or synthetic polymers to improve oral bioavailability of proteins and peptides. We also discuss formulation strategies to overcome barriers, therapeutic efficacies in vivo, and potential benefits and issues for successful oral dosage forms of the proteins and peptides.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26027575     DOI: 10.2174/1381612821666150531163944

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  11 in total

1.  The Sustained Effects on Tear Volume of Pilocarpine Hydrochloride in Gelatin by Hydrogel Administered by An Implant-mediated Drug Delivery System.

Authors:  Seunghee Cha; Hong-Kyun Kim; Hong-Seop Kho; Young-Seok Park
Journal:  Curr Drug Deliv       Date:  2017       Impact factor: 2.565

2.  Methanobactin reverses acute liver failure in a rat model of Wilson disease.

Authors:  Josef Lichtmannegger; Christin Leitzinger; Ralf Wimmer; Sabine Schmitt; Sabine Schulz; Yaschar Kabiri; Carola Eberhagen; Tamara Rieder; Dirk Janik; Frauke Neff; Beate K Straub; Peter Schirmacher; Alan A DiSpirito; Nathan Bandow; Bipin S Baral; Andrew Flatley; Elisabeth Kremmer; Gerald Denk; Florian P Reiter; Simon Hohenester; Friedericke Eckardt-Schupp; Norbert A Dencher; Jerzy Adamski; Vanessa Sauer; Christoph Niemietz; Hartmut H J Schmidt; Uta Merle; Daniel Nils Gotthardt; Guido Kroemer; Karl Heinz Weiss; Hans Zischka
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

Review 3.  Fluorescent Reporters and Biosensors for Probing the Dynamic Behavior of Protein Kinases.

Authors:  Juan A González-Vera; May C Morris
Journal:  Proteomes       Date:  2015-11-04

4.  Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin.

Authors:  Haisheng He; Yi Lu; Jianping Qi; Weili Zhao; Xiaochun Dong; Wei Wu
Journal:  Acta Pharm Sin B       Date:  2017-12-23       Impact factor: 11.413

5.  Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect.

Authors:  Rudra Pangeni; Jeong Uk Choi; Vijay Kumar Panthi; Youngro Byun; Jin Woo Park
Journal:  Int J Nanomedicine       Date:  2018-06-06

6.  Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier.

Authors:  Lorena M Coria; Gabriela S Risso; Francisco F Guaimas; Mariana C Ferrero; Laura Bruno; Karina A Pasquevich; Juliana Cassataro
Journal:  J Control Release       Date:  2018-11-27       Impact factor: 9.776

7.  Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin.

Authors:  Christine M Martin; Vadivel Parthsarathy; Annie Hasib; Ming T Ng; Stephen McClean; Peter R Flatt; Victor A Gault; Nigel Irwin
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

8.  Preparation and in vivo evaluation of an orally available enteric-microencapsulated parathyroid hormone (1-34)-deoxycholic acid nanocomplex.

Authors:  Seung Rim Hwang; Dong-Hyun Seo; Youngro Byun; Jin Woo Park
Journal:  Int J Nanomedicine       Date:  2016-08-31

9.  Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivative.

Authors:  Rudra Pangeni; Saurav Kumar Jha; Ruby Maharjan; Jeong Uk Choi; Kwan-Young Chang; Young Kweon Choi; Youngro Byun; Jin Woo Park
Journal:  Int J Nanomedicine       Date:  2019-08-08

Review 10.  Recent Advances in Encapsulation, Protection, and Oral Delivery of Bioactive Proteins and Peptides using Colloidal Systems.

Authors:  Sarah L Perry; David Julian McClements
Journal:  Molecules       Date:  2020-03-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.